Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
The NFκB Signaling Pathway Is Involved in the Pathophysiological Process of Preeclampsia
Yaxi Li1, Qinying Zhu1, Ruifen He1
1The First Clinical Medical College of Lanzhou University, Lanzhou, China.
Insights
Preeclampsia (PE) poses significant risks to mothers and infants. This review explores the role of Nuclear Factor kappa B (NFκB) in PE, examining its involvement in current and potential therapeutic strategies.
Area of Science:
- Reproductive biology
- Immunology
- Molecular biology
Background:
- Preeclampsia (PE) is a leading cause of maternal and fetal mortality with long-term health implications.
- Current treatment for PE involves pregnancy termination, highlighting the need for novel therapeutic strategies.
- The Nuclear Factor kappa B (NFκB) signaling pathway is crucial in regulating inflammation and innate immunity.
Purpose of the Study:
- To review the multifaceted role of NFκB in normal pregnancy and preeclampsia.
- To analyze the involvement of NFκB in established preeclampsia treatment modalities.
- To identify and discuss potential therapeutic strategies targeting NFκB for preeclampsia management.
Main Methods:
- Literature review of studies on NFκB signaling in pregnancy.
- Analysis of NFκB's role in the pathogenesis of preeclampsia.
- Examination of existing and proposed therapeutic interventions targeting NFκB pathways.
Main Results:
- NFκB plays a significant role in the inflammatory processes underlying preeclampsia.
- Dysregulation of NFκB signaling is implicated in the pathophysiology of PE.
- Targeting NFκB presents a promising avenue for developing new preeclampsia treatments.
Conclusions:
- Understanding NFκB's role is critical for advancing preeclampsia research.
- NFκB-targeted therapies offer potential for improved maternal and fetal outcomes in PE.
- Further investigation into NFκB modulation is warranted for effective preeclampsia treatment.
Abstract:
The high prevalence of preeclampsia (PE) is a major cause of maternal and fetal mortality and affects the long-term prognosis of both mother and baby. Termination of pregnancy is currently the only effective treatment for PE, so there is an urgent need for research into its pathogenesis and the development of new therapeutic approaches. The NFκB family of transcription factors has an essential role in inflammation and innate immunity. In this review, we summarize the role of NFκB in normal and preeclampsia pregnancies, the role of NFκB in existing treatment strategies, and potential NFκB treatment strategies.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Regulation of the Unfolded Protein Response
Hormonal Regulation